BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
4/9/2025 1:05:44 PM | Browse: 156 | Download: 638
 |
Received |
|
2024-11-06 10:07 |
|
Peer-Review Started |
|
2024-11-13 02:46 |
|
First Decision by Editorial Office Director |
|
2025-02-13 03:31 |
|
Return for Revision |
|
2025-02-13 03:31 |
|
Revised |
|
2025-02-21 11:53 |
 |
Publication Fee Transferred |
|
|
|
Second Decision by Editor |
|
2025-03-03 02:44 |
|
Second Decision by Editor-in-Chief |
|
|
|
Final Decision by Editorial Office Director |
|
2025-03-04 12:05 |
|
Articles in Press |
|
2025-03-04 12:05 |
|
Edit the Manuscript by Language Editor |
|
|
|
Typeset the Manuscript |
|
2025-03-26 02:06 |
|
Publish the Manuscript Online |
|
2025-04-09 13:05 |
| ISSN |
2220-6124 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2025. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Urology & Nephrology |
| Manuscript Type |
Prospective Study |
| Article Title |
Modified National Early Warning Score 2, a reliable early warning system for predicting treatment outcomes in patients with emphysematous pyelonephritis
|
| Manuscript Source |
Invited Manuscript |
| All Author List |
Sriram Krishnamoorthy, Gayathri Thiruvengadam, Hariharasudhan Sekar, Velmurugan Palaniyandi, Srinivasan Ramadurai and Senthil Narayanasamy |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
Sriram Krishnamoorthy, Professor, Department of Urology and Renal Transplantation, Sri Ramachandra Institute of Higher Education and Research, 1 Ramachandra Nagar, Porur, Chennai 600116, Tamil Nādu, India. sriramuro@gmail.com |
| Key Words |
Pyelonephritis; Emphysematous; Nephrectomy; National Early Warning Score 2; Mortality |
| Core Tip |
We present the most extensive single-centre study on patients diagnosed with emphysematous pyelonephritis (EPN), comprehensively evaluating risk stratification, disease severity, and treatment outcomes. While the traditional National Early Warning Score 2 (NEWS 2) score is a well-established tool for triaging critically ill patients in emergency settings, its ability to predict long-term treatment outcomes in EPN remains limited. The modified NEWS 2 score proposed in this study enhances risk differentiation, allowing for more accurate prognostication and timely clinical decision-making. This refined scoring system enables optimized resource allocation, early intensive care unit admission, and tailored treatment approaches, ultimately improving patient survival and reducing morbidity in EPN. |
| Publish Date |
2025-04-09 13:05 |
| Citation |
Krishnamoorthy S, Thiruvengadam G, Sekar H, Palaniyandi V, Ramadurai S, Narayanasamy S. Modified National Early Warning Score 2, a reliable early warning system for predicting treatment outcomes in patients with emphysematous pyelonephritis. World J Nephrol 2025; 14(2): 103035 |
| URL |
https://www.wjgnet.com/2220-6124/full/v14/i2/103035.htm |
| DOI |
https://dx.doi.org/10.5527/wjn.v14.i2.103035 |
All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.
